Patents by Inventor Jens Schroder
Jens Schroder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11951733Abstract: The invention relates to a printing machine with hybrid printing technology for printing on a continuous material web.Type: GrantFiled: December 4, 2020Date of Patent: April 9, 2024Assignee: Windmöller & Hölscher KGInventors: Sven Michael, Thomas Boosmann, Wolfgang Cordroch, Ralph Luxem, Jens Voelschow, Christian Bruns, Nico Schröder, Martin Flaspöhler, Nils-Henrik Schirmeisen
-
Publication number: 20240083857Abstract: The present invention describes 2-methyl-quinazoline compounds of general formula (I), methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions. The 2-methyl substituted quinazoline compounds of general formula (I) effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are therefore useful for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, such as cancer as a sole agent or in combination with other active ingredients.Type: ApplicationFiled: July 11, 2023Publication date: March 14, 2024Inventors: Lars WORTMANN, Brice SAUTIER, Knut EIS, Hans BRIEM, Niels BOHNKE, Franz VON NUSSBAUM, Roman HILLIG, Benjamin BADER, Jens SCHRODER, Kirstin PETERSEN, Philip LIENAU, Antje Margret WENGNER, Dieter MOOSMAYER, Qiuwen WANG, Hans SCHICK
-
Publication number: 20230416249Abstract: Compounds of formula (I) processes for their production and their use as pharmaceuticals.Type: ApplicationFiled: May 10, 2023Publication date: December 28, 2023Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.Inventors: Stephan SIEGEL, Franziska SIEGEL, Volker SCHULZE, Markus BERGER, Keith GRAHAM, Ulrich KLAR, Jeremie Xavier G. MORTIER, Detlev SÜLZLE, Ulf BÖMER, Daniel KORR, Jens SCHRÖDER, Matthew MEYERSON, Heidi GREULICH, Bethany KAPLAN
-
Patent number: 11685608Abstract: The invention relates to an apparatus for the single-track or multi-track conveying of objects along a conveying path extending in a conveying direction, wherein the conveying path for at least one track comprises at least one conveying device that takes over objects at the input side from a functional unit connected upstream and that transfers objects at the output side to a functional unit connected downstream; and wherein the conveying device as a whole and/or in an output-side end region is adjustable transversely to the conveying direction by means of an adjustment device such that the transverse position of objects to be transferred is changed within the respective track.Type: GrantFiled: March 27, 2020Date of Patent: June 27, 2023Assignee: WEBER MASCHINENBAU GMBH BREIDENBACHInventor: Jens Schröder
-
Publication number: 20230064983Abstract: Compounds of formula (I) processes for their production and their use as pharmaceuticals.Type: ApplicationFiled: September 22, 2022Publication date: March 2, 2023Applicants: Bayer Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.Inventors: Stephan SIEGEL, Franziska SIEGEL, Volker SCHULZE, Markus BERGER, Jeremie Xavier G. MORTIER, Detlev SÜLZLE, Ulf BÖMER, Daniel KORR, Jens SCHRÖDER, Ursula MÖNNING, Michael NIEHUES, Matthew MEYERSON, Heidi GREULICH, Bethany KAPLAN
-
Publication number: 20220378762Abstract: Compounds of formula (I) for use in the treatment or prophylaxis of a disease, which is a hyperproliferative disease and/or a disorder responsive to induction of cell death, selected from a haematological tumour, a solid tumour and/or metastases thereof, said tumour harbouring a mutant EGFR with exon 19 or 21 mutations, and their use as pharmaceuticals.Type: ApplicationFiled: April 22, 2020Publication date: December 1, 2022Applicants: Bayer Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.Inventors: Franziska SIEGEL, Daniel KORR, Jens SCHRÖDER, Stephan SIEGEL, Heidi GREULICH, Bethany KAPLAN, Matthew MEYERSON
-
Publication number: 20220298157Abstract: Compounds of formula (I), formula (I), processes for their production and their R use as pharmaceuticals.Type: ApplicationFiled: April 22, 2020Publication date: September 22, 2022Applicants: Bayer Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.Inventors: Stephan SIEGEL, Franziska SIEGEL, Volker SCHULZE, Markus BERGER, Keith GRAHAM, Detlev SÜLZLE, Ulf BÖMER, Daniel KORR, Jens SCHRÖDER, Ursula MÖNNING, Michael NIEHUES, Matthew MEYERSON, Heidi GREULICH, Bethany KAPLAN
-
Publication number: 20220274979Abstract: The present invention covers 2-methyl-aza-quinazoline compounds of general formula (I) as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredientsType: ApplicationFiled: April 15, 2019Publication date: September 1, 2022Applicants: Bayer Pharma Aktiengesellschaft, Bayer Healthcare ChinaInventors: Lars WORTMANN, Brice SAUTIER, Knut EIS, Hans BRIEM, Niels BÖHNKE, Franz VON NUSSBAUM, Roman HILIG, Benjamin BADER, Jens SCHRÖDER, Kirstin PETERSEN, Philip LIENAU, Antje Margret WENGNER, Dieter MOOSMAYER, Qiuwen WANG, Hans SCHICK
-
Publication number: 20220235013Abstract: The present invention describes 2-methyl-quinazoline compounds of general formula (I), methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions. The 2-methyl substituted quinazoline compounds of general formula (I) effectively and selectively inhibit the Ras-Sos interaction without significantly targeting the EGFR receptor. They are therefore useful for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, such as cancer as a sole agent or in combination with other active ingredients.Type: ApplicationFiled: March 19, 2018Publication date: July 28, 2022Applicant: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Lars WORTMANN, Brice SAUTIER, Knut EIS, Hans BRIEM, Niels BOHNKE, Franz VON NUSSBAUM, Roman HILLIG, Benjamin BADER, Jens SCHRODER, Kirstin PETERSEN, Philip LIENAU, Antje Margret WENGNER, Dieter MOOSMAYER, Qiuwen WANG, Hans SCHICK
-
Publication number: 20220227729Abstract: The present invention relates to compounds of formula (1) in which A, U and R1 are as defined herein, to pharmaceutical compositions and combinations comprising the compounds according to the invention, and to the prophylactic and therapeutic use of the inventive compounds, respectively to the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for neoplastic disorders, respectively cancer or conditions with dysregulated immune responses or other disorders associated with aberrant KRAS signaling, as a sole agent or in combination with other active ingredients.Type: ApplicationFiled: May 14, 2020Publication date: July 21, 2022Applicant: Bayer AktiengesellschaftInventors: Duy NGUYEN, Knut EIS, Jeremie Xavier MORTIER, Hans BRIEM, Clara CHRIST, Anders Roland FRIBERG, Benjamin BADER, Patrick STEIGEMANN, Volker BADOCK, Jens SCHRÖDER, Franziska SIEGEL, Dieter MOOSMAYER
-
Publication number: 20220151282Abstract: A process for producing dimensionally stable food products continuously introduces food raw materials and water into the housing of an extruder. At least one screw is arranged in the housing. The screw is rotated to generate a mixture of the food raw materials in the housing. A section ahead of the outlet of the housing is controlled to heat the mixture to at least 60° C. to produce a cooked mass from the mixture. The cooked mass is discharged from the outlet and deposited on a carrier. The carrier is moved in a controlled manner relative to the outlet to produce form-stable food products on the carrier. The depositing of the cooked mass takes place in directly adjacent lanes into mass strips, which preferably lie in at least two planes on top of one another. .Type: ApplicationFiled: September 8, 2021Publication date: May 19, 2022Inventors: Volker Lammers, Lars Leonhardt, Jens Schröder, Josef Müller
-
Patent number: 10894784Abstract: The present invention covers heteroarylbenzimidazole compounds of general formula (I) in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative and/or inflammatory disorders, as a sole agent or in combination with other active ingredients.Type: GrantFiled: December 15, 2016Date of Patent: January 19, 2021Assignee: BAYER PHARMA AKTIENGESELLSCHAFTInventors: Volker Schulze, Tobias Heinrich, Florian Prinz, Julien Lefranc, Jens Schröder, Anne Mengel, Wilhelm Bone, Joszef Bálint, Antje Margret Wengner, Knut Eis, Horst Irlbacher, Marcus Koppitz, Ulf Bömer, Benjamin Bader, Hans Briem, Philip Lienau, Clara Christ, Detlef Stöckigt, Roman Hillig
-
Publication number: 20200307916Abstract: The invention relates to an apparatus for the single-track or multi-track conveying of objects along a conveying path extending in a conveying direction, wherein the conveying path for at least one track comprises at least one conveying device that takes over objects at the input side from a functional unit connected upstream and that transfers objects at the output side to a functional unit connected downstream; and wherein the conveying device as a whole and/or in an output-side end region is adjustable transversely to the conveying direction by means of an adjustment device such that the transverse position of objects to be transferred is changed within the respective track.Type: ApplicationFiled: March 27, 2020Publication date: October 1, 2020Inventor: Jens Schröder
-
Patent number: 10737403Abstract: The invention relates to a device for moving portions, which each comprise at least one slice cut from a food product, in particular by means of a slicing device, in particular a high-speed slicer, comprising a plurality of individually movable transport movers each for at least one portion, a track system for the transport movers, in which track system the transport movers can be moved along at least one specified track in a transport direction, and a control apparatus for controlling the movements of the transport movers in the track system, wherein the transport movers each comprise at least one runner that interacts with the track system and at least one carrier for at least one portion, the at least one carrier being attached to the runner by means of a retainer, and wherein the drive for each transport mover is formed by the runner and the track system, which together form an electromagnetic drive for the transport mover.Type: GrantFiled: April 22, 2015Date of Patent: August 11, 2020Assignee: Weber Maschinenbau GmbH BreidenbachInventors: Sigfrid Bauer, Alexander Burk, Christoph Eckhardt, Theodor Horst, Christoph Kuhmichel, Stefan Lehmann, Gerd Lischinski, Thomas Nispel, Ingo Rother, Jens Schroder, Leopold Von Keudell, Steffen Zecher
-
Patent number: 10428044Abstract: Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.Type: GrantFiled: June 17, 2015Date of Patent: October 1, 2019Assignee: Bayer Pharma AktiengesellschaftInventors: Keith Graham, Ulrich Klar, Hans Briem, Marion Hitchcock, Lars Bärfacker, Knut Eis, Volker Schulze, Gerhard Siemeister, Wilhelm Bone, Jens Schröder, Simon Holton, Philip Lienau, René Tempel, Helmut Sonnenschein, Jozsef Bálint, Heinz Graubaum
-
Patent number: 10350206Abstract: Compounds of formula (I) as defined herein and their use as pharmaceuticals.Type: GrantFiled: September 17, 2015Date of Patent: July 16, 2019Assignee: Bayer Pharma AktiengesellschaftInventors: Anne Mengel, Hans-Georg Lerchen, Manfred Möwes, Thomas Müller, Lars Bärfacker, Marion Hitchcock, Arwed Cleve, Joachim Kuhnke, Hans Briem, Gerhard Siemeister, Wilhelm Bone, Amaury Ernesto Fernandez-Montalvan, Jens Schröder, Ursula Mönning, Simon Holton
-
Publication number: 20190047980Abstract: The present invention covers heteroarylbenzimidazole compounds of general formula (I) in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative and/or inflammatory disorders, as a sole agent or in combination with other active ingredients.Type: ApplicationFiled: December 15, 2016Publication date: February 14, 2019Inventors: Volker SCHULZE, Tobias HEINRICH, Florian PRINZ, Julien LEFRANC, Jens SCHRÖDER, Anne MENGEL, Wilhelm BONE, Joszef BÁLINT, Antje Margret WENGNER, Knut EIS, Horst IRLBACHER, Marcus KOPPITZ, Ulf BÖMER, Benjamin BADER, Hans BRIEM, Philip LIENAU, Clara CHRIST, Detlef STÖCKIGT, Roman HILLIG
-
Publication number: 20170305882Abstract: Compounds of formula (I) and their use as pharmaceuticals.Type: ApplicationFiled: September 17, 2015Publication date: October 26, 2017Applicant: Bayer Pharma AktiengesellschaftInventors: Anne MENGEL, Hans-Georg LERCHEN, Thomas MÜLLER, Lars BÄRFACKER, Marion HITCHCOCK, Arwed CLEVE, Hans BRIEM, Gerhard SIEMEISTER, Wilhelm BONE, Amaury Ernesto FERNÁNDEZ-MONTÁLVAN, Jens SCHRÖDER, Ursula MÖNNING, Simon HOLTON
-
Publication number: 20170283396Abstract: Compounds of formula (I) which are inhibitors of Bub 1 kinase, processes for their production and their use as pharmaceuticals.Type: ApplicationFiled: March 28, 2017Publication date: October 5, 2017Applicant: Bayer Pharma AktiengesellschaftInventors: Christoph-Stephan HILGER, Marion HITCHCOCK, Hans BRIEM, Gerhard SIEMEISTER, Amaury Ernesto FERNANDEZ-MONTALVAN, Jens SCHRÖDER, Simon HOLTON, Cornelia PREUßE, Karsten DENNER
-
Publication number: 20170275269Abstract: Compounds of formula (I) and their use as pharmaceuticals.Type: ApplicationFiled: September 17, 2015Publication date: September 28, 2017Applicant: Bayer Pharma AktiengesellschaftInventors: Anne MENGEL, Thomas MÜLLER, Lars BÄRFACKER, Marion HITCHCOCK, Arwed CLEVE, Hans BRIEM, Gerhard SIEMEISTER, Wilhelm BONE, Amaury Ernesto FERNANDEZ-MONTALVAN, Jens SCHRÖDER, Ursula MÖNNING